BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35068222)

  • 1. Identification of a 7-miRNA signature for predicting the prognosis of patients with lung adenocarcinoma.
    Liu R; Guo Z; Huang J; Li J; Tan Q; Luo Q
    Exp Biol Med (Maywood); 2022 Apr; 247(8):641-657. PubMed ID: 35068222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma.
    Wang H; Wei C; Pan P; Yuan F; Cheng J
    Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six MicroRNA Prognostic Models for Overall Survival of Lung Adenocarcinoma.
    Li J; Gu X; Gao C; Zhang J
    Genet Res (Camb); 2022; 2022():5955052. PubMed ID: 36101742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma.
    Li X; Shi Y; Yin Z; Xue X; Zhou B
    J Transl Med; 2014 Jun; 12():159. PubMed ID: 24893932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis and Validation of the Prognosis ability of the M7GRelated miRNAs in Lung Adenocarcinoma.
    Qiu X; Chen Y; Zhu X; Gong Z; Yu F; Zhang P; Song Y; Li H
    Asian Pac J Cancer Prev; 2023 Apr; 24(4):1275-1287. PubMed ID: 37116150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
    Zhou J; Wang X; Li Z; Jiang R
    Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma.
    Li W; Liu S; Su S; Chen Y; Sun G
    PeerJ; 2021; 9():e10470. PubMed ID: 33510968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of metabolism-related gene signature in lung adenocarcinoma.
    Wang N; Wang H
    Medicine (Baltimore); 2023 Nov; 102(47):e36267. PubMed ID: 38013279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a 4-miRNA prognostic signature for endometrial cancer.
    Huang J; Du F; Wang N
    Medicine (Baltimore); 2022 Oct; 101(41):e30974. PubMed ID: 36254064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
    Tan J; Wang W; Song B; Song Y; Meng Z
    Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
    Wu P; Zheng Y; Wang Y; Wang Y; Liang N
    J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and validation of a prognostic model for lung adenocarcinoma based on endoplasmic reticulum stress-related genes.
    Li F; Niu Y; Zhao W; Yan C; Qi Y
    Sci Rep; 2022 Nov; 12(1):19857. PubMed ID: 36400857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-related gene signature for predicting LUAD patients' prognosis and immune microenvironment.
    Chen J; Fu Y; Hu J; He J
    Cytokine; 2022 Apr; 152():155820. PubMed ID: 35176657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of miRNA Biomarkers in Predicting Overall Survival Outcomes for Lung Adenocarcinoma.
    Li T; Liu H; Dong C; Lyu J
    Biomed Res Int; 2022; 2022():5249576. PubMed ID: 36147635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal Expression and Prognostic Significance of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma.
    Xu Z; Chen C
    Biomed Res Int; 2021; 2021():6663990. PubMed ID: 34036102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Three Differentially Expressed miRNAs as Potential Biomarkers for Lung Adenocarcinoma Prognosis.
    Wang W; Liu B; Duan X; Feng X; Wang T; Wang P; Ding M; Zhang Q; Feng F; Wu Y; Yao W; Wang Q; Yang Y
    Comb Chem High Throughput Screen; 2020; 23(2):148-156. PubMed ID: 31976830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA expression profile and TNM staging system predict survival in patients with lung adenocarcinoma.
    Xin G; Cao X; Zhao W; Lv P; Qiu G; Li Y; Wang B; Fang B; Jia Y
    Math Biosci Eng; 2020 Nov; 17(6):8074-8083. PubMed ID: 33378933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a Four-Gene Signature Associated with the Prognosis Prediction of Lung Adenocarcinoma Based on Integrated Bioinformatics Analysis.
    Wu Y; Yang L; Zhang L; Zheng X; Xu H; Wang K; Weng X
    Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a four-gene panel predicting overall survival for lung adenocarcinoma.
    Li C; Long Q; Zhang D; Li J; Zhang X
    BMC Cancer; 2020 Dec; 20(1):1198. PubMed ID: 33287749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.